Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06379243
Other study ID # KY-2023-008-02
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 1, 2023
Est. completion date December 31, 2027

Study information

Verified date April 2024
Source The Seventh Affiliated Hospital of Sun Yat-sen University
Contact jinhui cai
Phone +86 18002299663
Email caijinhui123456@163.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this project, IDEAL-IQ technology and PDFF and R2* image-based imaging methods are used to analyze the intrinsic relationship between preoperative vertebral bone marrow fat content, magnetic susceptibility properties of bone tissue and bone strength (bone volume and bone mass), to explore the mechanism of vertebral re-fracture after PVP / PKP, and to explore the imaging markers for the risk of postoperative vertebral re-fracture after PVP / PKP. To construct a precise and individualized risk assessment model of vertebral re-fracture after PVP/ PKP by combining clinical risk factors, preoperative quantitative MRI parameters (PDFF, R2*) and imaging characteristics, so as to achieve the goal of objectively and accurately evaluating the risk of vertebral re-fracture at the early stage of the postoperative period (1 year).


Recruitment information / eligibility

Status Recruiting
Enrollment 560
Est. completion date December 31, 2027
Est. primary completion date December 31, 2026
Accepts healthy volunteers No
Gender All
Age group 50 Years to 90 Years
Eligibility Inclusion Criteria: - Patients diagnosed with osteoporotic vertebral fractures of the thoracic and lumbar level with reference to the 2022 edition of the Osteoporotic Fractures Guidelines (2022 edition); - The presence of bone marrow edema or hemorrhage (acute fracture) in the fractured vertebrae is clearly defined by MR examination, and the responsible vertebrae is treated with PVP / PKP; - Number of fractured vertebrae: 1-3 vertebral compression fractures (including old fractures). Exclusion Criteria: - History of severe scoliosis, vertebroplasty, or internal spinal fixation; - Presence of spinal infection and malignant neoplastic disease; - Presence of mental disease, cognitive impairment, or critical illness (e.g., severe cardiac or cerebrovascular disease).

Study Design


Intervention

Procedure:
PVP/PKP
PVP or PKP surgery in patients with osteoporotic vertebral compression fractures

Locations

Country Name City State
China The Seventh Affiliated Hospital, Sun Yat-sen University Guangzhou Guangdong

Sponsors (4)

Lead Sponsor Collaborator
The Seventh Affiliated Hospital of Sun Yat-sen University Dongguan Hospital of Traditional Chinese Medicine, Huizhou Municipal Central Hospital, The Fourth Affiliated Hospital of Guangzhou Medical University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Non-operative vertebral re-fracture within 1 year after PVP / PKP Non-operative vertebral re-fracture within 1 year after PVP / PKP, confirmed by follow-up spinal MRI 1 year
Secondary Visual Analog Score (VAS) at 1 year after PVP/ PKP Visual Analog Score (VAS) at 1 year after PVP / PKP were obtained by completing the appropriate questionnaires on-site at the time of the 1-year postoperative spinal MRI review. 1 year
Secondary Oswestry Dysfunction Index (ODI) at 1 year after PVP/PKP Oswestry Dysfunction Index (ODI) at 1 year after PVP / PKP were obtained by completing the appropriate questionnaires on-site at the time of the 1-year postoperative spinal MRI review. 1 year
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06024148 - Continuation of Anti-osteoporotic Treatment 1 Year After Initial Administration
Completed NCT03710889 - Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption Phase 3
Recruiting NCT05058976 - Romosozumab Use to Build Skeletal Integrity Phase 4
Completed NCT03798444 - Height Loss, Kyphosis Indicators, Bone Mineral Density and Vertebral Fractures in Chinese Postmenopausal Women
Completed NCT04960033 - Evaluating Fracture Risk Assessment Tools (FRAX) From Different Regions in Central South Chinese Postmenopausal Women
Completed NCT05366621 - Post-fracture Medication and Mortality
Not yet recruiting NCT04597931 - Evaluation of Romosozumab vs. Zoledronic Acid Effect in Patients With Spinal Cord Injury and Low Bone Mineral Density Phase 4
Completed NCT02483286 - Osteoporosis and Fall Prevention With Multiple Interventions in the Metropolitan Area N/A
Enrolling by invitation NCT03178799 - Randomized Fracture Liaison Services
Completed NCT02803190 - Osteoporosis and Fall Prevention and Posture Correction Interventions in the Metropolitan Area N/A
Recruiting NCT03451305 - Postrual Reduction With Pillow in Osteoporotic Vertebral Fracture N/A
Recruiting NCT03811509 - Breast Cancer Women on Aromatase Inhibitors Treatment Phase 4